ADJ
Commercial- Indications
- Vaccine adjuvant
Company intelligence / Profile preview
Advanced Bioadjuvants LLC develops and produces proprietary adjuvant formulations such as Adjuplex, which are used to enhance the effectiveness of vaccines. Their products have been referenced in government contracts for research purposes but there is no public record of clinical trial results in humans. The company appears active in supplying adjuvant technologies primarily for research, development, and possibly commercial use within agriculture or veterinary sectors rather than direct pharmaceutical applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Bioadjuvants LLC.